Search

Your search keyword '"Thomas, DM"' showing total 708 results

Search Constraints

Start Over You searched for: Author "Thomas, DM" Remove constraint Author: "Thomas, DM"
708 results on '"Thomas, DM"'

Search Results

1. ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue

2. Progress towards increased understanding and control of internal transport barriers in DIII-D

3. Long pulse high performance discharges in the DIII-D tokamak

4. Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.

5. Modified study designs to expand treatment options in personalised oncology: a multistakeholder view

6. Heritable defects in telomere and mitotic function selectively predispose to sarcomas

7. Family communication and results disclosure after germline sequencing: A mixed methods study.

8. Higher fusion power gain with profile control in DIII-D tokamak plasmas

9. Stability in high gain plasmas in DIII-D*

10. Local analysis of confinement and transport in neutral beam heated DIII-D discharges with negative magnetic shear

11. Higher Fusion Power Gain with Current and Pressure Profile Control in Strongly Shaped DIII-D Tokamak Plasmas

12. Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results

13. Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results

14. Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting

15. In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer

16. Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.

17. Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients.

18. Cancer patient knowledge about and behavioral intentions after germline genome sequencing.

19. Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study.

20. Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients.

21. Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L

22. Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling

23. Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling

24. Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study

25. Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients

26. Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: 'Another piece of the pie'

27. Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology

28. ClinSV: clinical grade structural and copy number variant detection from whole genome sequencing data

29. Family communication about genomic sequencing: A qualitative study with cancer patients and relatives

30. Cancer patient knowledge about and behavioral intentions after germline genome sequencing

31. Fear of cancer recurrence in patients undergoing germline genome sequencing

32. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

34. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

35. Family communication about genomic sequencing: A qualitative study with cancer patients and relatives

36. Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling

37. Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer

39. Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

40. Author Correction: Diagnosis of fusion genes using targeted RNA sequencing (Nature Communications, (2019), 10, 1, (1388), 10.1038/s41467-019-09374-9)

41. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

42. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer

43. Cancer patients' views and understanding of genome sequencing: A qualitative study

44. The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly

45. BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis

46. Who should access germline genome sequencing? A mixed methods study of patient views.

47. Who should access germline genome sequencing? A mixed methods study of patient views

48. The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design

49. Diagnosis of fusion genes using targeted RNA sequencing

50. Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases

Catalog

Books, media, physical & digital resources